GlassScriptPhysician profile
Jennifer L Lambert
NPI 1467549865
$829.28
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $214 · 2021: $233 · 2022: $86.63.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $187.52 | 2019-2022 | |
| Glaxosmithkline, LLC. | $180.07 | 2019-2021 | |
| Novo Nordisk INC | $134.64 | 2019-2021 | |
| Lilly USA, LLC | $84.07 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $40.81 | 2020-2022 | |
| Pfizer INC. | $40.68 | 2019-2020 | |
| Abbott Laboratories | $37.40 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.14 | 2021 | |
| Eisai INC. | $18.92 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.55 | 2022 | |
| Merck Sharp & Dohme LLC | $14.91 | 2019 | |
| Amgen INC. | $14.23 | 2019 | |
| Shire North American Group INC | $14.03 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.31 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.